229 related articles for article (PubMed ID: 8585729)
1. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.
Stapleton P; Wu PJ; King A; Shannon K; French G; Phillips I
Antimicrob Agents Chemother; 1995 Nov; 39(11):2478-83. PubMed ID: 8585729
[TBL] [Abstract][Full Text] [Related]
2. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
[TBL] [Abstract][Full Text] [Related]
3. Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States.
Kaye KS; Gold HS; Schwaber MJ; Venkataraman L; Qi Y; De Girolami PC; Samore MH; Anderson G; Rasheed JK; Tenover FC
Antimicrob Agents Chemother; 2004 May; 48(5):1520-5. PubMed ID: 15105100
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.
Wu PJ; Shannon K; Phillips I
Antimicrob Agents Chemother; 1994 Mar; 38(3):494-8. PubMed ID: 8203843
[TBL] [Abstract][Full Text] [Related]
5. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.
Sirot D; Chanal C; Henquell C; Labia R; Sirot J; Cluzel R
J Antimicrob Chemother; 1994 Jun; 33(6):1117-26. PubMed ID: 7928805
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
Livermore DM; Seetulsingh P
J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.
Leflon-Guibout V; Speldooren V; Heym B; Nicolas-Chanoine M
Antimicrob Agents Chemother; 2000 Oct; 44(10):2709-14. PubMed ID: 10991849
[TBL] [Abstract][Full Text] [Related]
8. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.
Lemozy J; Sirot D; Chanal C; Huc C; Labia R; Dabernat H; Sirot J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2580-2. PubMed ID: 8585751
[TBL] [Abstract][Full Text] [Related]
9. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
Zhou XY; Bordon F; Sirot D; Kitzis MD; Gutmann L
Antimicrob Agents Chemother; 1994 May; 38(5):1085-9. PubMed ID: 8067742
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of reduced susceptibility to amoxycillin-clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain).
Pérez-Moreno MO; Pérez-Moreno M; Carulla M; Rubio C; Jardí AM; Zaragoza J
Clin Microbiol Infect; 2004 Mar; 10(3):234-41. PubMed ID: 15008945
[TBL] [Abstract][Full Text] [Related]
11. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
Seetulsingh PS; Hall LM; Livermore DM
J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
Marre R; Schulz E
Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli.
Henquell C; Chanal C; Sirot D; Labia R; Sirot J
Antimicrob Agents Chemother; 1995 Feb; 39(2):427-30. PubMed ID: 7726509
[TBL] [Abstract][Full Text] [Related]
14. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.
Di Conza JA; Badaracco A; Ayala J; Rodríguez C; Famiglietti A; Gutkind GO
Rev Argent Microbiol; 2014; 46(3):210-7. PubMed ID: 25444130
[TBL] [Abstract][Full Text] [Related]
15. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.
Oliver A; Pérez-Vázquez M; Martínez-Ferrer M; Baquero F; De Rafael L; Cantón R
Antimicrob Agents Chemother; 1999 Apr; 43(4):862-7. PubMed ID: 10103192
[TBL] [Abstract][Full Text] [Related]
16. Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France.
Henquell C; Sirot D; Chanal C; De Champs C; Chatron P; Lafeuille B; Texier P; Sirot J; Cluzel R
J Antimicrob Chemother; 1994 Nov; 34(5):707-14. PubMed ID: 7706166
[TBL] [Abstract][Full Text] [Related]
17. Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group.
Chardon H; Farzaneh S; Labia R; Jarlier V; Nicolas MH; Paul G; Poyart C; Sirot D; Sirot J
J Antimicrob Chemother; 1995 Jul; 36(1):267-9. PubMed ID: 8537279
[No Abstract] [Full Text] [Related]
18. β-Lactamases in amoxicillin-clavulanate-resistant Escherichia coli strains isolated from a Chinese tertiary hospital.
Ding J; Ma X; Chen Z; Feng K
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):532-3. PubMed ID: 23726651
[TBL] [Abstract][Full Text] [Related]
19. Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR.
Speldooren V; Heym B; Labia R; Nicolas-Chanoine MH
Antimicrob Agents Chemother; 1998 Apr; 42(4):879-84. PubMed ID: 9559800
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
Gatermann S; Marre R
Infection; 1991; 19(2):106-9. PubMed ID: 1646771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]